Covestor Ltd Acquires 723 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Covestor Ltd lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 30.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,073 shares of the medical instruments supplier’s stock after buying an additional 723 shares during the quarter. Covestor Ltd’s holdings in DENTSPLY SIRONA were worth $102,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of XRAY. Principal Securities Inc. bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $26,000. Headlands Technologies LLC purchased a new position in DENTSPLY SIRONA in the 4th quarter worth about $30,000. Parkside Financial Bank & Trust lifted its holdings in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 292 shares in the last quarter. VisionPoint Advisory Group LLC boosted its position in DENTSPLY SIRONA by 57.1% in the 4th quarter. VisionPoint Advisory Group LLC now owns 1,216 shares of the medical instruments supplier’s stock valued at $43,000 after buying an additional 442 shares during the period. Finally, GAMMA Investing LLC bought a new position in DENTSPLY SIRONA in the 4th quarter worth about $55,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Down 0.9 %

Shares of DENTSPLY SIRONA stock traded down $0.23 on Tuesday, reaching $26.16. The stock had a trading volume of 477,901 shares, compared to its average volume of 3,123,990. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $5.43 billion, a P/E ratio of -59.43, a P/E/G ratio of 1.18 and a beta of 1.01. The company has a 50 day moving average price of $26.47 and a 200 day moving average price of $30.62. DENTSPLY SIRONA Inc. has a 1 year low of $23.94 and a 1 year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the previous year, the company earned $0.39 earnings per share. The business’s revenue for the quarter was down 2.6% on a year-over-year basis. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.02 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.45%. The ex-dividend date was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was purchased at an average cost of $27.95 per share, with a total value of $99,977.15. Following the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.52% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday. Needham & Company LLC lowered their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Piper Sandler restated a “neutral” rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Finally, StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.